ARCHIVES

Afinitor Approved for Rare Disorder

This article is from The Cancer Letter archive.

Vol. 36 No. 40 | November 5, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Adds $700,000 to CCOP Budget, Makes Four New Awards

June 9, 1989

Risks Of Long-Term HRT Outweigh Benefits, WHI Finds

March 28, 2008

Nancy Brinker Resigns As CEO of Komen

August 10, 2012

Reorganization Answer Now Coming In – Viroloy Extramural Research To Be Under Carcinogenesis

March 24, 1978

In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State

July 30, 1993

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993